Inventor · disambiguated record
Alfonso Pozzan
Also filed as: POZZAN ALFONSO
9 granted patents·9 pending applications·42 citations·filing 2001–2025
82Inventor score
Files withDENALI THERAPEUTICS INC8PHARMACYCLICS LLC2ALIHODZIC SULEJMAN1AMGEN INC1CHRONOS THERAPEUTICS LTD1
Top patents by PatentIndex Score
18 records- 0197US9815850B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·36 cites·41 claims
- 0286US10604535B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2018·Granted Mar 31, 2020·3 cites·18 claims
- 0386US10131676B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2017·Granted Nov 20, 2018·3 cites·33 claims
- 0485US12358928B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·8 claims
- 0584US2025388601A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0673US2023043400A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0769US2020317691A1Compounds, Compositions and MethodsDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0858US2021070748A1Inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 0952US12473289B2Heterocyclic compounds as delta-5 desaturase inhibitors and methods of useAMGEN INC·Filed 2020·Granted Nov 18, 2025·0 cites·10 claims
- 1048US2023115176A1Complement Modulators and Related MethodsRA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1143US2005215495A1Macrolide antibioticsALIHODZIC SULEJMAN·Filed 2005·Application pending·0 cites
- 1243US2018305348A1Inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 1342US2004077557A1Macrolide antibioticsFiled 2001·Application pending·0 cites
- 1442US2010286152A1N-phenyl hydrazides as modulators of the ghrelin receptorGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1540US11660293B2Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonistsCHRONOS THERAPEUTICS LTD·Filed 2018·Granted May 30, 2023·0 cites·20 claims
- 1640US10709692B2Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1)DENALI THERAPEUTICS INC·Filed 2016·Granted Jul 14, 2020·0 cites·28 claims
- 1737US9181259B2Substituted pyrrolo[1,2-a]piperazines and pyrrolo[1,2-a][1,4]diazepines as neurokinin 1 receptor antagonistsLEO PHARMA AS·Filed 2013·Granted Nov 10, 2015·0 cites·25 claims
- 1833US7262172B2MacrolidesGLAXOSMITHKLINE ZAGREB·Filed 2001·Granted Aug 28, 2007·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →